Semaglutide: Impact on Healthcare Costs and Potential Weight Loss Benefits

This chapter discusses the potential impact of the drug Semaglutide on healthcare costs and its sustained weight loss benefits. It emphasizes the need to consider the price net of discounts and highlights projections for US prescription drug spending in 2030. The chapter also explores the affordability of Semaglutide for Medicare beneficiaries and the potential combination of Kagrillion-tide and C. McLutide for weight loss.